Subdividing ovarian and peritoneal serous carcinoma into moderately differentiated and poorly differentiated does not have biologic validity based on molecular genetic and in vitro drug resistance data.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples